Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to EMD Serono
Related studies linked through entity extraction aliases.
Avelumab and M1774 in ARID1A-mutated Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE2
FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
- Status
- RECRUITING
- Phase
- N/A
Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Patient-Centered Care Survey
- Status
- COMPLETED
- Phase
- N/A
Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study
- Status
- COMPLETED
- Phase
- N/A
A Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine Tablets
- Status
- RECRUITING
- Phase
- PHASE4
Aerobic Exercise for Remyelination in Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cladribine Tablets After Treatment With Natalizumab (CLADRINA)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Validation of a Shared Decision-Making Tool for Multiple Sclerosis
- Status
- COMPLETED
- Phase
- NA
Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE4
Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas
- Status
- COMPLETED
- Phase
- PHASE2
Avelumab Plus 2nd-generation ADT in African American Subjects With mCRPC
- Status
- TERMINATED
- Phase
- PHASE2
Avelumab and Radiation in Muscle-Invasive Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE2
The UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy
- Status
- TERMINATED
- Phase
- PHASE2